Thomas A. Mitro
Net Worth
Last updated:
What is Thomas A. Mitro net worth?
The estimated net worth of Mr. Thomas A. Mitro is at least $20,493,000 as of 27 Aug 2018. He has earned $11,520,840 from insider trading and has received compensation worth at least $8,972,160 in Aerie Pharmaceuticals, Inc..
What is the salary of Thomas A. Mitro?
Mr. Thomas A. Mitro salary is $747,680 per year as Pres & Chief Operating Officer in Aerie Pharmaceuticals, Inc..
How old is Thomas A. Mitro?
Mr. Thomas A. Mitro is 67 years old, born in 1958.
What stocks does Thomas A. Mitro currently own?
As insider, Mr. Thomas A. Mitro owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Aerie Pharmaceuticals, Inc. (AERI) | Pres & Chief Operating Officer | 51,479 | $0 | $0 |
What does Aerie Pharmaceuticals, Inc. do?
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension; and Rocklatan, a once-daily fixed-dose combination of Rhopressa and latanopros to reduce IOP to treat patients with open-angle glaucoma or ocular hypertension. The company also develops AR-15512 to treat signs and symptoms of dry eye; and AR-1105 and AR-14034 SR sustained-release implants focused on retinal diseases. It has a collaborative research, development, and licensing agreement with DSM Biomedical. Aerie Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Durham, North Carolina.
Thomas A. Mitro insider trading
Aerie Pharmaceuticals, Inc.
Mr. Thomas A. Mitro has made only one insider trade between 2013-2018, according to the Form 4 filled with the SEC.
As of 27 Aug 2018 he still owns at least 51,479 units of AERI stock.
Aerie Pharmaceuticals key executives
Aerie Pharmaceuticals, Inc. executives and other stock owners filed with the SEC:
- Dr. Benjamin F. McGraw III, J.D., Pharm.D. (76) Executive Chairman
- Dr. Casey C. Kopczynski (64) Co-Founder & Chief Scientific Officer
- Dr. David A. Hollander M.B.A., M.D. (51) Chief R&D Officer
- Mr. John W. LaRocca Esq. (60) Gen. Counsel & Sec.
- Mr. Thomas A. Mitro (67) Pres & Chief Operating Officer